Clinical trial Recruiting at 5 sites Interventional Ages 18 and up Women only

Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy

Official title: Specific and Novel Approaches to Care of Inflammatory Bowel Disease During Pregnancy: the PREGO Study

Run by Austin Health · NCT07916727 · Data updated 2026-11-12

This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment50 (estimated)
SponsorAustin Health
Government
Locations7 sites (Hobart and 6 other locations)
StatusRecruiting
StartedApril 15, 2026
Main results expectedDecember 2027
Study endsMarch 2028
Registry record updatedNovember 4, 2026
Trial IDNCT07916727 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Biologically female adults (18+) with diagnosed IBD who are pregnant and currently receiving dedicated IBD pregnancy care at participating centers in Australia.

Probably not a fit

Pregnant patients with IBD who are managed outside participating centers or who do not opt into the virtual care component may not experience the proposed benefits.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial explores the value of multidisciplinary care for pregnant patients with inflammatory bowel disease and introduces a virtual-based delivery method to increase access. It aims to determine whether coordinated, specialized care can reduce variation in treatment and improve healthcare delivery during pregnancy. The study involves adult, biologically female participants with IBD who are pregnant and receiving dedicated IBD pregnancy care at participating centers. Interventions focus on a structured, pregnancy-specific IBD care pathway delivered across traditional and virtual platforms at multiple Australian sites. Outcomes will inform how best to organize care for IBD in pregnancy and whether virtual care adds meaningful benefit.

Why it matters

Potential benefit: If successful, patients could experience more consistent, accessible, and coordinated care during pregnancy, potentially improving maternal and fetal outcomes.

How similar studies have gone: Prior research suggests multidisciplinary care approaches can improve outcomes in complex IBD management, but the addition of virtual care in pregnancy remains an area of active evaluation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Biologically female adult patients (aged 18 years or older) with a diagnosis of inflammatory bowel disease (IBD) receiving care for their IBD during pregnancy

Exclusion Criteria:

* Non-pregnant inflammatory bowel disease patients
* Non-consenting patients
* Age \<18
* Pregnant patients with inflammatory bowel disease receiving dedicated IBD pregnancy care at an alternative tertiary institution

Where it's running

  • Austin Health
    Melbourne, Australia
    Recruiting
  • Eastern Health
    Melbourne, Australia
    Recruiting
  • Mercy Health
    Melbourne, Australia
    Recruiting
  • Royal Prince Alfred Hospital
    Sydney, Australia
    Recruiting
  • St Vincent's Hospital Darlinghurst
    Sydney, Australia
    Recruiting
  • Royal Hobart Hospital
    Hobart, Australia
    Not yet recruiting
Show 1 more location
  • Peninsula Health
    Melbourne, Australia
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.